Maverick Therapeutics, Inc.

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

Sanofi is to pay $1bn up front to acquire privately held biotech Amunix Pharmaceuticals, Inc. , which is developing products designed to overcome safety issues that have hampered the development of

Taking ‘Journey’ Together Helped Forge Gilead/Glympse NASH Biomarker Deal Many partnerships come together after some initial work together. Glympse Bio CEO Caroline Loew explained during a BIO Digit

Nearly 3,500 gene, cell and RNA therapies are in development across the world, with 77 of them in Phase III trials, and the first quarter of 2021 saw 13 start-ups raise $480m as the space continues to